Trials / Completed
CompletedNCT03079557
Feasibility Pilot for the ReBOO-trial
A Non-randomised, Open Feasibility Pilot for the 'REpurposing BOtulinum Toxin in Treatment of Obesity in Adolescents' (ReBOO) Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- St. Olavs Hospital · Academic / Other
- Sex
- All
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot testing the feasibility of the 'REpurposing BOtulinum Toxin in Treatment of Obesity in Adolescents' trial (ReBOO-trial). The full-scale ReBOO will further investigate safety and efficacy of intragastric injections of botulinum toxin A into the antrum area of the stomach. These injections will be repeated every six months. The study sample will be adolescents with obesity who have not responded to standard conservative treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intragastric botulinum toxin type A | 200 units Botulinum toxin A (Allergan) injected intragastrically in the antrum every six months |
Timeline
- Start date
- 2017-03-14
- Primary completion
- 2019-04-30
- Completion
- 2019-04-30
- First posted
- 2017-03-14
- Last updated
- 2020-09-22
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT03079557. Inclusion in this directory is not an endorsement.